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One of the most important developments in clinical immunology in the past decade 
has  been  the  demonstration  of increased  frequencies  of specific  histocompatibility 
antigens in individuals with a  variety of diseases, implying that genes predisposing to 
the disorders  reside in or near the major histocompatibility complex.  The increased 
prevalence  of the  antigens  HLA-B8,  HLA-Dw3,  and  HLA-DRw3  in  a  number  of 
organ-specific autoimmune diseases suggests that a gene in the HLA region, associated 
with  these alleles,  may predispose  to the development  of autoimmunity.  One of the 
HLA-B8-associated diseases  is Sjogren's syndrome, an autoimmune disorder charac- 
terized by lymphocytic infiltrates of salivary, lacrimal, and other exocrine glands. 
We  reported  (1)  an  impaired  lymphocyte response  to  suboptimally  stimulating 
concentrations of phytohemagglutinin (PHA) in Sjogren's syndrome. This abnormal- 
ity of lymphocyte activation occurs almost exclusively in patients  with HLA-B8 (2), 
and  we  hypothesized  that  it  might  reflect  the  action  of a  gene  predisposing  to 
autoimmunity. 
To elucidate the possible etiological significance of this lymphocyte abnormality in 
Sjogren's syndrome, we examined the lymphocyte responses of healthy young adults 
with  or without  HLA-B8.  We now report  that  most normal  subjects  with  HLA-B8 
have  a  similar  impairment  of  lymphocyte  activation  in  response  to  suboptimal 
concentrations of PHA. The decreased proliferation  is also apparent  in the response 
to  suboptimal  concentrations  of concanavalin  A  (Con  A)  but  not  to  optimally 
stimulating  concentrations  of either  mitogen.  Subjects  with  HLA-B8  had  similar 
percentages of T  lymphocytes, and the abnormality could be demonstrated in highly 
purified suspensions of T  cells. 
Materials  and Methods 
Subjects.  Clinically healthy Caucasian college students were typed for HLA antigens using 
trays purchased from Dr. Paul Terasaki,  UCLA, Los Angeles, CA. All subjects were negative 
for rheumatoid  factor and  anti-nuclear  antibodies.  To  minimize  experiment-to-experiment 
variability, the following protocol was used for assays of mitogen responsiveness.  Two or three 
individuals with HLA-B8, an equal number of  age- and sex-matched controls, and an additional 
reference individual  were included  in each experiment.  The results of six experiments  were 
combined and the data normalized, based upon the response of the reference individual, who 
was included in all experiments. 
HLA  Typing.  HLA antigens of the A, B, C, and DR loci were detected by the microlym- 
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phocyte  cytotoxicity method  (3)  using  typing trays  purchased  from  Dr.  Terasaki.  Rabbit 
complement, prescreened for effectiveness and  lack of toxicity, was obtained from Accurate 
Chemical  and  Scientific Co.,  Westbury,  NY.  For  HLA-DR  typing,  B  lymphocytes  were 
recovered from soda-straw nylon wool columns (4). 
Cell Preparation.  Human  peripheral  blood  was  obtained  by  venipuncture  from  normal 
subjects. Mononuclear cells were separated from heparinized blood by centrifugation on Ficoll- 
Hypaque gradients (5). Cells were washed three times before being placed in culture. 
DNA  synthesis in  response  to  mitogens was  measured  as previously described  (6).  Final 
concentrations of PHA used included 0.05/zg/ml, 0.075 #g/ml, 0.1 #g/ml, 0.5 #g/ml, and  1.0 
/zg/ml. Final concentrations of Con A included 0.5 #g/ml, 1/zg/ml, 3.3 #g/ml, and  10/zg/ml. 
For most subjects, 1.0 #g/ml of PHA and 10 #g/ml of Con A resulted in an optimal proliferative 
response. 
Cell Separation and Identification.  Sephadex G-10 bead columns were prepared according to 
the method of Ly and Mishell (7), with the following modifications (8). Columns were prepared 
in  12-ml syringes, plugged with a  small amount  of glass wool. 9 ml of Sephadex beads were 
added to each column. Up to  1 ×  10  ~ peripheral blood mononuclear cells were added to the 
column in 1 ml of RPMI with 5% fetal calf serum (FCS). Columns were incubated at 37°C for 
30 min and stirred gently with a  pipette at  10-rain intervals. After incubation, nonadherent 
cells were flushed from the column in 25-30 ml of RPMI with FCS. 
T  lymphocytes were purified by passage over nylon wool columns, according to the method 
of Julius  (9),  except that  a  preliminary passage over Sephadex columns was substituted for 
preliminary passage over glass wool columns. T  lymphocytes capable of forming rosettes with 
sheep erythrocytes were identified by the method of  Jondal (10). Peripheral blood mononuelear 
cells were mixed with washed sheep erythrocytes at a ratio of 1:200. The cells were pelleted and 
allowed to sit at room temperature overnight. After gentle resuspension, lymphocytes binding 
three or more erythrocytes were counted. Monocytes were identified by staining slides prepared 
in a Shandon cytocentrifuge for myeloperoxidase (11,  12). Cells recovered from such a double- 
column passage contained ~ 1% monocytes and 0.3%  B cells (by staining for surface immuno- 
globulin (Ig). 
Statistical  Analysis.  The  data  presented  are  the  means  of  quadruplicate  cultures  after 
subtraction of unstimulated (background) incorporation. In analyzing proliferative responses, 
geometric means were used to reflect the logarithmic nature of the data. 
Results 
Mitogen Responses.  When peripheral blood mononuclear cells from clinically nor- 
mal  young  adults  with  and  without  HLA-B8  were  cultured  with  suboptimally 
stimulating concentrations of PHA, most of the subjects with HLA-B8 demonstrated 
an  impaired proliferative response.  In  response  to 0.1  /zg/ml of PHA,  lymphocytes 
from 9 out of 15 HLA-B8-positive subjects incorporated <2,500 cpm, compared with 
only  1  out  of  15  subjects  without  HLA-B8  (Fig.  1A).  The  mean  response  of the 
subjects with HLA-B8 was 1,919 cpm, significantly less than the response (6,384 cpm) 
of the subjects without  HLA-B8 (P <  0.007). This concentration of PHA is -10%  of 
the optimal concentration. 
Many of the healthy subjects with  HLA-B8 also had a  low response to a  subopti- 
mally stimulating concentration  (0.5  g/ml)  of the  mitogen  Con  A  (Fig.  1 B).  The 
mean response of the HLA-B8 group (5,559 cpm) was significantly less than the mean 
response  (11,550  cpm)  of healthy subjects without  this antigen  (P <  0.009).  Of the 
nine  HLA-B8-positive subjects  with  suboptimal  PHA  responses  below  2,500  cpm, 
seven also had suboptimal Con A  responses below 4,000 cpm. Lymphocyte prolifera- 
tion in response to an optimally stimulating concentration  of PHA  (1.0 #g/ml)  did 
not differ significantly in the two groups. 
Subjects with  HLA-B8 tended to have somewhat lower responses to an optimally 
stimulating concentration of Con A  (10/zg/ml)  than  the HLA-B8-negative subjects, 938 
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l"[c.  1.  Lymphocyte responses of clinically normal subjects with (0) or without (O) HLA-B8. Bars 
indicate geometric means. (A) response to 0.1 ttg/ml PHA. HLA-B8-positive subjects; mean = 3.283 
-+ 0. I432. HLA-B8-negative subjects; mean = 3.805 + 0.1315; t = 2.648; P< 0.007. (B) response to 
0.5 ttg/ml Con A. HLA-B8-positive subjects; mean =  3.745 ::t: 0.0861. HLA-B8-negative subjects; 
mean = 4.062 + 0.0904. t = 2.543; P < 0.009. 
but the difference between the two groups was not significant (P <  0.07). Of the nine 
subjects with HLA-B8, who had optimal Con A  responses below 60,000 cpm, eight of 
these individuals also had suboptimal PHA responses below 2,500. 
HLA-DR  Typing.  HLA antigens of the DR locus were determined for 11 clinically 
normal subjects with the antigen HLA-B8. Of the 11 HLA-B8-positive subjects typed, 
9  also had  the associated antigen DRw3.  Of the two subjects without  HLA-DRw3, 
one  had  a  response  to suboptimal  PHA  of 2,812  cpm, just  above the  mean  of the 
HLA-B8 group. The other subject without DRw3 had a suboptimal PHA response of 
263 cpm, the lowest response in the study. 
Percentages of T  Cells and Monocytes in Peripheral Blood of Normal Subjects with or without 
HLA-8.  After isolation ofmononuclear cells on Ficoll-Hypaque gradients, an average 
of  1.18  ×  107  cells per  10  ml  of blood was  recovered  from  subjects with  HLA-B8, 
compared with  1.77 X  107 cells per 10 ml of blood from subjects without this antigen. 
The lower cell recovery from blood from HLA-B8 subjects was not due to a  decreased 
percentage of T  iymphocytes in HLA-B8 subjects, as 56.9% of the mononuclear cells 
formed  rosettes,  compared  with  57.0%  of  cells  from  subjects  without  HLA-B8. 
Significantly fewer peroxidase-positive monocytes  were  observed on  cytospin slides 
from HLA-B8-positive subjects (24.8%), compared with subjects without this antigen 
(39.5%). 
Functional Impairment  of T  Lymphocytes.  In  experiments  designed to determine  the 
cellular  basis  of  the  abnormal  PHA  response,  T  lymphocytes  were  purified  by 
sequential passage over Sephadex G-10 and nylon wool columns. Three experiments McCOMBS  AND  MICHALSKI  BRIEF  DEFINITIVE  REPORT  939 
TABLE  I 
Impaired PHA Response of Subjects with HLA-B8 Is Attributable to T Lymphocytes 
Experiment 
Normal subject  Percent per-  Normal subject  Percent per- 
oxide staining  oxidase stain-  Cell preparation  with HLA-B8  without HLA-B8 
monocytes  ing monocytes 
1  Unseparated cells  3,445 ±  242*  (13.3%)  14,065 ±  204  (28.9%) 
T  lymphocytes~:  1,648 ±  327  (2.0%)  6,737 ±  316  (2.0%) 
2  Unseparated cells  2,982 ±  134  (11.5%)  8,468 ±  303  (21.8%) 
T  lymphocytes  533 ±  67  (0.3%)  2,802 ±  236  (0.5%) 
3  Unseparated cells  9,3% ±  1651  (I 7.5%)  33,245 ±  1,081  (17.5%) 
T  lymphocytes  572 +  21  (0.6%)  14,185 ±  1,413  (1.0%) 
* Incorporation of tritiated thymidine in response to 0.1/~g/ml PHA. Results expressed as net cpm ±  SE. 
:~ T  lymphoeytes were purified by passage over Sephadex G-10 columns followed by passage over nylon wool columns. 
using this protocol are shown in Table I. Highly purified T  cells proliferated less in 
response to a suboptimal concentration of PHA than did the original cell suspensions, 
but when subjects with or without HLA-B8 were compared, in each case the purified 
T  cells from the subjects with HLA-B8 retained the same impaired response relative 
to the non-HLA-B8 subjects. 
Discussion 
The mechanism of genetic predisposition to autoimmune disorders is unknown, but 
may involve HLA-linked immune response genes, susceptibility to infectious agents, 
or the action of other genes in the HLA region that are involved in immune functions. 
Several previous studies as well as our own results suggest that a gene associated with 
HLA-B8  may  act  through  an  effect  on  the  immune  system  that  is  detectable  in 
clinically normal individuals. 
Lymphocyte proliferation in vitro to wheat gluten has been reported to be signifi- 
cantly more frequent in HLA-B8-positive normal subjects than in those without this 
antigen  (13).  Among patients with skin cancer, a  significant correlation of HLA-B8 
with  large  tumors  and  with  low T  cell  levels  has been  reported  (14).  A  study by 
Greenburg and  Yunis  (15)  found  a  decreased  PHA response by lymphocytes from 
normal women with HLA-B8. 
Lawley and associates (16)  recently reported that normal subjects with the HLA- 
B8/DRw3  haplotype had delayed Fc receptor-mediated clearance of IgG-sensitized 
erythrocytes, decreased percentages and total numbers of T  cells bearing Fc receptors 
for IgG, decreased Con A responses, and increased numbers of circulating spontaneous 
Ig-secreting cells. 
Ambinder  and  associates  (17)  recently  reported  that  lymphocytes from  normal 
subjects  with  HLA-DR3  developed  increased  numbers  of plaque-forming cells  in 
culture and have decreased Con A-induced suppression. 
Our results indicate that healthy young adults with the antigen HLA-B8 have an 
abnormality of lymphocyte function that is expressed in vitro as a  decreased ability 
to proliferate in response to suboptimal concentrations of PHA and Con A. The fact 
that  the  lymphocyte  abnormality  is  a  discrete  defect  of response  to  suboptimal 
concentrations of PHA, while the response to higher concentrations is normal, offers 
a clue to the possible mechanism. The response to suboptimal mitogen concentrations 
differs from the response of optimal concentrations in several respects. 
First, the response to a  suboptimal concentration of PHA is highly dependent  on 
cellular interactions,  whereas the response to optimal concentrations is not. Oppen- 
heim and associates (18) as well as ourselves (6) have shown that depleting monocytes 940  McCOMBS AND MICHALSKI  BRIEF  DEFINITIVE REPORT 
or macrophages decreases the response to suboptimal  concentrations far more than 
optimal responses. 
Second, the cells proliferating in response to suboptimal concentrations of mitogens 
may represent  a  distinct  T  cell subpopulation.  Schlossman  and  his  associates  (19) 
have shown that only the OKT4+ subpopulation responds to suboptimal concentra- 
tions of PHA. 
A third difference between suboptimum and optimum responses is that suboptimal 
mitogen responses are far more sensitive to inhibition by physiological concentrations 
of hydrocortisone, histamine,  interferon, isoproterenol, and  prostaglandins  (20,  21). 
The reason for the differential sensitivity of suboptimal responses to these agents is 
unclear, but  it appears that  optimal concentrations of mitogens bypass or override 
regulatory mechanisms. 
The results of cell separation  experiments suggest  that  the defect of lymphocyte 
activation is intrinsic to the T  lymphocytes because purified T  cells from HLA-B8- 
positive subjects  show  the  same  relative impairment  compared  with  T  cells  from 
subjects without this antigen. Although we found no difference in the total numbers 
of T  lymphocytes, a  qualitative  or  quantitative  abnormality  of a  T  lymphocyte 
subpopulation remains a possibility. 
Like other investigators, we used HLA-B8 as a convenient marker gene. We presume 
that the gene responsible for the lymphocyte defect, like the gene thought to predispose 
to autoimmunity, is in linkage disequilibrium with HLA-B8, Dw3, and DRw3. The 
fact  that  some  individuals  with  HLA-B8  have  responses  to  suboptimal  mitogen 
concentrations well within  the  range of individuals  without  this  antigen,  confirms 
that the gene responsible is not HLA-B8 per se. The finding that one of two HLA-B8- 
positive subjects in this study, who lacked HLA-DRw3, also has a  greatly impaired 
response, suggests that the responsible gene is also not DRw3 per se. 
Our  observation  of a  defect of lymphocyte activation  associated  with  HLA-B8 
patients with Sjogren's syndrome led us to hypothesize that this abnormality might 
directly reflect the action of the gene associated with HLA-BS, which predisposes to 
autoimmunity.  Our demonstration that  many healthy young adults with  HLA-B8 
have a similar abnormality indicates that the lymphocyte defect has a direct genetic 
basis, precedes the development of autoimmunity, and might, therefore, be of etiolog- 
ical significance. Further analysis of this in vitro abnormality might help to elucidate 
the mode of action of the responsible gene. 
We are very grateful to Irene De  Jesus and Janet Anderson for outstanding technical assistance. 
Summary 
We have reported that abnormal lymphocyte function in Sjogren's syndrome occurs 
almost  exclusively in  patients  with  HLA-BS.  We  now  report  that  most  clinically 
normal individuals with this antigen have a similar impairment of cellular immunity. 
This finding suggests that the lymphocyte abnormality in Sjogren's syndrome is not 
secondary to the disease process or medication and  might have primary etiological 
significance. The lymphocyte abnormality is expressed as  a  decreased proliferative 
response to suboptimally stimulating concentrations of phytohemagglutinin  (PHA) 
and  concanavalin  A  (Con  A).  In  contrast,  the  response  to  optimally  stimulating 
concentrations of PHA and Con A is unaffected. The impaired mitogen responsiveness 
appears to be intrinsic to the T  lymphocytes, as it can be demonstrated in purified T 
cell preparations. McCOMBS  AND MICHALSKI  BRIEF DEFINITIVE REPORT  941 
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